DK3642365T3 - Cirkulerende serum-mikro-rna-biomarkører og fremgangsmåder til bestemmelse af progressionsraten af parkinsons sygdom - Google Patents
Cirkulerende serum-mikro-rna-biomarkører og fremgangsmåder til bestemmelse af progressionsraten af parkinsons sygdom Download PDFInfo
- Publication number
- DK3642365T3 DK3642365T3 DK18737451.7T DK18737451T DK3642365T3 DK 3642365 T3 DK3642365 T3 DK 3642365T3 DK 18737451 T DK18737451 T DK 18737451T DK 3642365 T3 DK3642365 T3 DK 3642365T3
- Authority
- DK
- Denmark
- Prior art keywords
- parkinson
- disease
- determining
- methods
- progression rate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762521797P | 2017-06-19 | 2017-06-19 | |
| PCT/US2018/036380 WO2018236590A1 (en) | 2017-06-19 | 2018-06-07 | CIRCULATING SERUM MICRO-RNA BIOMARKERS AND METHODS FOR DETERMINING THE SPEED OF PARKINSON'S DISEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3642365T3 true DK3642365T3 (da) | 2021-10-18 |
Family
ID=62817067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18737451.7T DK3642365T3 (da) | 2017-06-19 | 2018-06-07 | Cirkulerende serum-mikro-rna-biomarkører og fremgangsmåder til bestemmelse af progressionsraten af parkinsons sygdom |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11739384B2 (da) |
| EP (3) | EP4410998A3 (da) |
| JP (2) | JP2020523998A (da) |
| DK (1) | DK3642365T3 (da) |
| ES (1) | ES2890949T3 (da) |
| WO (1) | WO2018236590A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020113271A1 (en) * | 2018-12-04 | 2020-06-11 | La Trobe University | Methods of diagnosing a disease state |
| WO2021132725A1 (ja) * | 2019-12-27 | 2021-07-01 | 国立大学法人弘前大学 | 認知機能障害のバイオマーカー及びその検出薬、被験者の認知機能障害を検査する方法、認知機能障害の治療又は改善手段を被験者に提示する方法、並びに、認知機能障害の治療又は改善物質のスクリーニング方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10184151B2 (en) | 2011-10-11 | 2019-01-22 | The Brigham And Women's Hospital, Inc. | Micrornas in neurodegenerative disorders |
| US20130102485A1 (en) * | 2011-10-19 | 2013-04-25 | Inhan Lee | Method of Determining a Diseased State in a Subject |
| US9540692B2 (en) * | 2012-07-25 | 2017-01-10 | Rush University Medical Center | MiRNAs as novel therapeutic targets and diagnostic biomarkers for parkinsons disease |
| WO2014075822A1 (en) | 2012-11-16 | 2014-05-22 | Siemens Aktiengesellschaft | New diagnostic mirna markers for parkinson disease |
| EP2971132B1 (en) * | 2013-03-15 | 2020-05-06 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
| WO2015073972A1 (en) * | 2013-11-18 | 2015-05-21 | Diamir, Llc | METHODS OF USING mIRNAs FROM BODILY FLUIDS FOR DETECTION AND MONITORING OF PARKINSON'S DISEASE (PD) |
| EP3083986B1 (en) * | 2013-12-19 | 2020-05-27 | Hummingbird Diagnostics GmbH | Mirnas as non-invasive biomarkers for parkinson's disease |
| US10011875B2 (en) * | 2014-01-13 | 2018-07-03 | Trustees Of Boston University | Methods and assays relating to Huntingtons disease and Parkinson's disease |
| WO2015106273A2 (en) * | 2014-01-13 | 2015-07-16 | Trustees Of Boston University | Methods and assays relating to huntingtons disease and parkinson's disease |
-
2018
- 2018-06-07 DK DK18737451.7T patent/DK3642365T3/da active
- 2018-06-07 EP EP24180872.4A patent/EP4410998A3/en active Pending
- 2018-06-07 EP EP18737451.7A patent/EP3642365B1/en active Active
- 2018-06-07 WO PCT/US2018/036380 patent/WO2018236590A1/en unknown
- 2018-06-07 JP JP2019570487A patent/JP2020523998A/ja active Pending
- 2018-06-07 EP EP21194995.3A patent/EP3988674B1/en active Active
- 2018-06-07 ES ES18737451T patent/ES2890949T3/es active Active
- 2018-06-07 US US16/623,870 patent/US11739384B2/en active Active
-
2023
- 2023-04-28 JP JP2023075039A patent/JP2023095935A/ja active Pending
- 2023-08-21 US US18/452,778 patent/US20240018595A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3642365B1 (en) | 2021-09-15 |
| EP3988674C0 (en) | 2024-07-17 |
| WO2018236590A1 (en) | 2018-12-27 |
| EP4410998A2 (en) | 2024-08-07 |
| US11739384B2 (en) | 2023-08-29 |
| EP3988674A1 (en) | 2022-04-27 |
| JP2023095935A (ja) | 2023-07-06 |
| EP3988674B1 (en) | 2024-07-17 |
| US20240018595A1 (en) | 2024-01-18 |
| EP3642365A1 (en) | 2020-04-29 |
| US20210198737A1 (en) | 2021-07-01 |
| JP2020523998A (ja) | 2020-08-13 |
| EP4410998A3 (en) | 2024-10-23 |
| WO2018236590A8 (en) | 2021-04-22 |
| ES2890949T3 (es) | 2022-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3612675T3 (da) | Mikrofibrilleret cellulose med forbedrede egenskaber og fremgangsmåder til fremstilling af samme | |
| DK3383916T3 (da) | Anti-CD73-antistoffer og anvendelser deraf | |
| DK3488369T3 (da) | Bestemmelse af en optimal wellness-plan | |
| DK3443119T3 (da) | Fremgangsmåde til bestemmelse af lunge cancer | |
| KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
| DK3277717T3 (da) | En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf | |
| DK3673081T3 (da) | Nøjagtig og massivt parallel kvantificering af nukleinsyre | |
| DK3882357T3 (da) | Fremgangsmåder og sammensætninger til analyse af nukleinsyrer | |
| MA55748A (fr) | Procédés de détection d'aav | |
| DK3350220T3 (da) | Anti-pro/latente-myostatin-antistoffer og anvendelser deraf | |
| DK3740216T3 (da) | Fremgangsmåder til vurdering af virale vektorers transduktionsstyrke | |
| MA42971A (fr) | Anticorps anti-pdl1, anticorps anti-pld1 activables, et leurs procédés d'utilisation | |
| DK3701973T3 (da) | Plasmabaseret film og fremgangsmåder til fremstilling og anvendelse af samme | |
| FR3052891B1 (fr) | Procede d'estimation du facteur d'intensite des contraintes et procede de calcul de duree de vie associe | |
| DK3515832T3 (da) | Spunstromle med inderbeholder, inderbeholder og fremgangsmåde til fremstilling af spunstromlen | |
| DK3532499T3 (da) | ANTI-IL-33-antistoffer og anvendelser deraf | |
| DK3491025T3 (da) | Fcrn-antistoffer og anvendelsesmetoder heraf | |
| DK3402821T5 (da) | Psma-bindende antistof og anvendelser deraf | |
| IL272647A (en) | Methods for determining DNA without a donor cell without a donor genotype | |
| FR3031641B1 (fr) | Procede d'identification d'une entite | |
| DK3128910T3 (da) | Fremgangsmåde til bestemmelse af tværsnitsarealet og voluminet af et objekt | |
| EP3411500C0 (en) | CIRCULATING SERUM MICRORNA BIOMARKERS AND METHODS FOR DETERMINING PARKINSON'S DISEASE | |
| DK3759233T3 (da) | Bioluminescerende biosensor til detektering og kvantificering af biomolekyler | |
| DK3472338T3 (da) | Midler og fremgangsmåder til at modifikation af flere alleler | |
| DK3348635T3 (da) | Hidtil ukendt mutant af humant serumalbumin |